Publicaciones en colaboración con investigadoras/es de Hospital Universitario de Guadalajara (82)

2024

  1. 2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?

    Contact Dermatitis, Vol. 90, Núm. 5, pp. 507-513

  2. Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)

    Contact Dermatitis, Vol. 91, Núm. 5, pp. 404-411

  3. An emerging epidemic of allergic contact dermatitis due to phytonadione epoxide (oxidised vitamin K1)

    Contact Dermatitis, Vol. 91, Núm. 5, pp. 379-386

  4. Cosmetovigilance for infrequent allergens in Spain using a national online registry: The example of allergic contact dermatitis caused by phenylethyl resorcinol

    Contact Dermatitis, Vol. 90, Núm. 3, pp. 245-252

  5. Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC)

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 6, pp. 539-546

  6. Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023

    Contact Dermatitis

  7. Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019–2022 prospective study with cluster and network analysis

    Journal of the European Academy of Dermatology and Venereology

  8. Sensitization to textile dyes in Spain: Epidemiological situation (2019–2022)

    Contact Dermatitis, Vol. 90, Núm. 5, pp. 486-494

  9. Sodium metabisulfite a current low relevant allergen in Spain

    Journal of the European Academy of Dermatology and Venereology

2023

  1. Allergic contact dermatitis to alkyl glucosides: Epidemiological situation in Spain

    Journal of the European Academy of Dermatology and Venereology

  2. Correction: Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection (Trials, (2021), 22, 1, (851), 10.1186/s13063-021-05777-6)

    Trials

  3. Hypoxic burden to guide CPAP treatment allocation in patients with obstructive sleep apnoea: a post hoc study of the ISAACC trial

    The European respiratory journal, Vol. 62, Núm. 6

  4. Patch Testing in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain

    Dermatitis, Vol. 34, Núm. 4, pp. 315-322

  5. Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019–2021 epidemiological situation

    Contact Dermatitis, Vol. 88, Núm. 3, pp. 212-219

2022

  1. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients

    Transplantation, Vol. 106, Núm. 7, pp. 1430-1439

  2. Correlation of Anti-Tissue Transglutaminase Antibodies With the Mucosal Changes and IgA Status of Children With Celiac Disease

    Journal of pediatric gastroenterology and nutrition, Vol. 75, Núm. 6, pp. 743-748

  3. Descripción de las Unidades de Cuidados Respiratorios Intermedios (UCRI) antes y durante la pandemia SARS CoV 2

    Revista española de patología torácica, Vol. 34, Núm. 1, pp. 76-76

  4. Intermediate Respiratory Care Units (RICUs) During the COVID-19 Pandemic. The Reality

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 284-286

  5. Long-Term Effect of Obstructive Sleep Apnea and Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients with Acute Coronary Syndrome: A Clinical Trial

    Annals of the American Thoracic Society, Vol. 19, Núm. 10, pp. 1750-1759

  6. Non-invasive Respiratory Support in COVID-19: A Narrative Review

    Frontiers in Medicine, Vol. 8